Similarly, the placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) commonly used in predicting preeclampsia were also demonstrated to be useful in screening for fetal Hb Bart’s disease. This evidence concerns the gene GSTM1 and preeclampsia.